<DOC>
	<DOCNO>NCT00676091</DOCNO>
	<brief_summary>The purpose study analyze 13-valent pneumococcal vaccine give healthy infant Brazil safety tolerability , determine immune response vaccine .</brief_summary>
	<brief_title>Study Evaluating 13-valent Pneumococcal Conjugate Vaccine Healthy Infants Brazil</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Inclusion criterion : Healthy 1 month old infant Available duration study reachable telephone Able complete two blood drawing procedure study Exclusion criterion : Previous vaccination , contraindication history allergic reaction vaccine vaccine component Bleeding disorder , immune deficiency significant chronic congenital disease Previous receipt blood product immune globulin</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>54 Days</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Pneumococcal conjugate vaccine</keyword>
</DOC>